arrow
H

Helen Parker

University of Manchester
H指数:34
被引数:2,836

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrated multi-omic profiling reveals two distinct splenic marginal zone lymphoma subgroups with prognostic relevance

整合多组学分析揭示两种具有预后意义的脾边缘区淋巴瘤亚群

2026-05-280
OAAI
ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker

ATM畸变在慢性淋巴细胞白血病中:del(11q)而非ATM突变是预后不良的生物标志物

LEUKEMIA
IF13.4
2025-04-240
OA
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
LEUKEMIA
IF13.4
2022-12-2429
OAAI
High surface IgM levels associate with shorter response to ibrutinib and BTK bypass in patients with CLL

高表面IgM水平与CLL患者对ibrutinib和BTK旁路的较短反应相关

2022-09-266
OAAI
Single-nucleotide Fcγ receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphoma
2021-07-2911
OA
Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patients
2021-03-1115
OAAI
Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial
LEUKEMIA
IF13.4
2020-02-0337
OAAI
Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multicenter study
2020-01-2353
OAAI
Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials
2019-08-2125
OAAI